| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/16/2004 | CA2517097A1 Identification of antigen epitopes |
| 09/15/2004 | EP1457559A1 ARTIFICIAL ANTIBODY LIBRARY WITH SUPER−REPERTORY |
| 09/15/2004 | EP1457558A1 WEED CONTROLLER METABOLISM PROTEINS, GENES THEREOF AND USE OF THE SAME |
| 09/15/2004 | EP1457499A1 Inhibitors of extracellular Hsp90 |
| 09/15/2004 | EP1456670A2 Methods relating to treatment of atherosclerosis |
| 09/15/2004 | EP1456663A2 Method for determination of the responsiveness of an individual to mistletoe lectin |
| 09/15/2004 | EP1456653A2 Genes encoding g-protein coupled receptors and methods of use therefor |
| 09/15/2004 | EP1456652A2 Agents that modulate immune cell activation and methods of use thereof |
| 09/15/2004 | EP1456651A2 Self-assembly molecules |
| 09/15/2004 | EP1456410A2 Method for displaying loops from immunoglobulin domains in different contexts |
| 09/15/2004 | EP1456408A2 Susceptibility locus for schizophrenia |
| 09/15/2004 | EP1456402A2 Means for treatment of atherosclerosis |
| 09/15/2004 | EP1456386A2 Polycistronic expression of antibodies |
| 09/15/2004 | EP1456378A2 Il-17 like molecules and uses thereof |
| 09/15/2004 | EP1456365A2 Protein modification and maintenance molecules |
| 09/15/2004 | EP1456347A2 Antibodies that immunospecifically bind to blys |
| 09/15/2004 | EP1456241A2 Mono-and dual anti-cd4-rantes chemokine/cytokine constructs |
| 09/15/2004 | EP1456238A2 Production of f(ab')2 fragments in mammalian cells |
| 09/15/2004 | EP1456237A2 Method for cloning of variable domain sequences |
| 09/15/2004 | EP1456234A2 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 09/15/2004 | EP1456223A2 Rapidly maturing fluorescent proteins and methods for using the same |
| 09/15/2004 | EP1456222A2 Non-human primate fc receptors and methods of use |
| 09/15/2004 | EP1455827A1 Pecam-1 modulation |
| 09/15/2004 | EP1455825A2 Treating b-cell mediated diseases by modulating dr6 activity |
| 09/15/2004 | EP1455824A2 Lyophilized preparation containing antibodies to the egf receptor |
| 09/15/2004 | EP1455823A2 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 09/15/2004 | EP1455822A2 Lyophilized monoclonal antibody compositions |
| 09/15/2004 | EP1455821A2 Parathyroid hormone antibodies and related methods |
| 09/15/2004 | EP1455820A2 Targeted ligands |
| 09/15/2004 | EP1455819A1 Individualized anti-cancer antibodies |
| 09/15/2004 | EP1455812A2 Antagonist anti-cd40 monoclonal antibody therapy for multiple sclerosis treatment |
| 09/15/2004 | EP1418808A4 Imaging marker transgenes |
| 09/15/2004 | EP1144616B1 Method for producing antibody fragments |
| 09/15/2004 | EP1007095B1 CHIMERIC TOXINS COMPRISING GnRH FOR TARGETED THERAPY |
| 09/15/2004 | EP0942985B1 Broad-spectrum delta-endotoxins |
| 09/15/2004 | EP0841939B1 Therapeutic agents and autoimmune diseases |
| 09/15/2004 | EP0740553B1 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells |
| 09/15/2004 | EP0678523B1 Recombinant anti-hiv antibody and preparation thereof |
| 09/15/2004 | EP0647275B1 Cloning and expression of gonadotropin-releasing hormone receptor |
| 09/15/2004 | EP0624195B1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 09/15/2004 | CN1529754A Variable region of monoclonal antibody against HBV S-surface antigene and gene encoding same |
| 09/15/2004 | CN1529753A Disease-associated protein |
| 09/15/2004 | CN1529713A Compositions and methods for therapy and diagnosis of ovarian cancer |
| 09/15/2004 | CN1529710A Recombinant protective protein from streptococcus pneumoniae |
| 09/15/2004 | CN1529619A Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enbancing agents |
| 09/15/2004 | CN1529617A Method for treaing autoimmune diseases in subject and in vitro diagnostic assays |
| 09/15/2004 | CN1529611A Use of IL-18 inhibitors for treatment or prevention of sepsis |
| 09/15/2004 | CN1528792A Method for extracting red blood cell membrane extract and its use |
| 09/15/2004 | CN1528791A Specific monoclonal antibody against epitope of clygoprotein coding inactivated feline immunodeficiency virus |
| 09/15/2004 | CN1166777C Human Sel-10 polypeptides and polynucleotides that encode them |
| 09/15/2004 | CN1166772C Process for controlling sialylation of protein produced by mammalian cell culture |
| 09/15/2004 | CN1166686C New human protein with the function of inhibiting cancer cell growth and its coding sequence |
| 09/14/2004 | US6790950 Anti-bacterial vaccine compositions |
| 09/14/2004 | US6790949 Used in the development of a therapeutic agent for neuron or endocrine cell-related diseases; vesicle transport proteins |
| 09/14/2004 | US6790940 For high speed detection |
| 09/14/2004 | US6790939 Anti-PSCA antibodies |
| 09/14/2004 | US6790938 Human autoantibodies and antiidiotypic antibodies against blood platelet membrane proteins |
| 09/14/2004 | US6790937 Recombinant scFV antibodies specific to Eimeria spp. responsible for coccidiosis |
| 09/14/2004 | US6790826 Human haemopoietic maturation factor |
| 09/14/2004 | US6790662 Method of isolating CD8+ cells, and related hybridoma cells antibodies and polypeptides |
| 09/14/2004 | US6790656 Galanin receptors (galr2); involved in various neurological and neurodegenerative disorders and treatments |
| 09/14/2004 | US6790649 Phex gene (phosphate regulating gene with homologies to endopeptidases on x chromosome); for treatment of x-linked hypophosphatemia (xlh), a phosphate homeostasis disorder; retardation, bone, renal and metabolism disorders |
| 09/14/2004 | US6790639 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques |
| 09/14/2004 | US6790638 Method for selecting tumours expressing HLA-G, sensitive to anticancer treatment and uses |
| 09/14/2004 | US6790637 Mammalian gene, BCL-W, belongs to the BCL-2 family of apoptosis-controlling genes |
| 09/14/2004 | US6790630 Glycoproteins; pepsin inhibitors; for detection of heartworm infection in dogs, cats |
| 09/14/2004 | US6790629 Receptor polypeptide for use in the treatment and diagnosis of painful syndromes |
| 09/14/2004 | US6790626 Comprises preference for pyrimidine nucleotides (uridine triphosphate) over purine nucleotides; for determining ligand binding, detecting expression, drug screening, treatment |
| 09/14/2004 | US6790625 Antibodies to placental protein 13 |
| 09/14/2004 | US6790622 Tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof |
| 09/14/2004 | US6790448 Infection therapy |
| 09/14/2004 | US6790446 Campylobacter vaccine |
| 09/14/2004 | US6790444 Chimeric antibody comprising human immunoglobin constant region and murine variable region |
| 09/14/2004 | US6790443 Administering to the subject a therapeutically effective amount of an agent which inhibits binding of advanced glycation endproducts to any receptor for advanced glycation endproducts |
| 09/14/2004 | CA2073113C Conjugates |
| 09/14/2004 | CA2071924C Hepatocellular carcinoma oncogene |
| 09/10/2004 | WO2004076684A2 Compositions and methods for the detection of mammalian muscle troponin i |
| 09/10/2004 | WO2004076677A2 Monoclonal antibody production by ebv transformation of b cells |
| 09/10/2004 | WO2004076666A1 Gasdermin family |
| 09/10/2004 | WO2004076658A1 Monoclonal antibody, gene encoding the same, hybridoma, medicinal composition and diagnostic reagent |
| 09/10/2004 | WO2004076653A1 Fetal cell isolation and enrichment |
| 09/10/2004 | WO2004076644A2 A composition for delivering an agent to a target cell and uses thereof |
| 09/10/2004 | WO2004076636A2 A novel human g-protein coupled receptor, hgprbmy23, expressed highly in kidney |
| 09/10/2004 | WO2004076621A2 Compositions of nucleic acids for treating and detecting influenza virus |
| 09/10/2004 | WO2004076620A2 Human antibodies specific for interleukin 15 (il-15) |
| 09/10/2004 | WO2004076618A2 Genetically modified non-human mammals and cells |
| 09/10/2004 | WO2004076489A1 Modified antibody |
| 09/10/2004 | WO2004076488A1 A molecule which binds cd80 and cd86 |
| 09/10/2004 | WO2004076487A1 Antibody and use thereof |
| 09/10/2004 | WO2004076486A1 Method for reducing levels of c-reactive protein |
| 09/10/2004 | WO2004076485A1 Antibody purification by protein a and ion exchange chromatography |
| 09/10/2004 | WO2004076482A1 Soluble factor secreted by endothelial cells in blood vessels |
| 09/10/2004 | WO2004076480A1 Tumour marker and its use |
| 09/10/2004 | WO2004075988A2 Methods of immunomodulation in animals |
| 09/10/2004 | WO2004075842A2 Mrp3 genes and uses thereof |
| 09/10/2004 | WO2004075839A2 Methods and compositions for modulating apoptosis |
| 09/10/2004 | WO2004075838A2 Method and compositions for the treatment of meconium aspiration syndrome |
| 09/10/2004 | WO2004075837A2 Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury |
| 09/10/2004 | WO2004075835A2 Methods for the treatment of renal cell carcinoma |
| 09/10/2004 | WO2004075813A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep3 ii (prostaglandin e2 ep3 ii) |